Prognostic significance of left ventricular mass change during treatment of hypertension.

By R. Devereux, K. Wachtell, E. Gerdts, K. Boman, M. Nieminen, V. Papademetriou, J. Rokkedal, Katherine E. Harris, P. Aurup, B. Dahlöf. Journal of the American Medical Association (JAMA), 2004

898 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism

View Paper: https://www.semanticscholar.org/paper/9916226d840614f779d7d4072e0d1b7120c8451a

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

In Endocrinology, Diabetes and Metabolism

Philippe van de Borne

Citations in the corpus

The Relationship of Left Ventricular Mass and Geometry to Incident Cardiovascular Events: The MESA Study (2008, neutral): “Never 2,491 (52) 39 (34) 21 (54) 13 (28) Former 1,702 (36) 52 (45) 12 (31) 21 (45) Current 595 ( 12 ) 24 (21) 6 (15) 13 (28)”
The 2015 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. (2013, methodology): “This has been shown for the treatment-induced regression of electrocardiographic LVH (voltage or strain criteria), the echocardiographic LVH and the echocardiographically derived measures of LVM and left atrial size [150,151,261,684–686].”
Expert consensus document on arterial stiffness: methodological issues and clinical applications. (2006, background): “These recommendations were issued long ago before the LIFE and RENAAL trials showed unequivocally that the regression of LVH and albuminuria, respectively, were predictive of the reduction in CV events.(162,163) Since 2003, corresponding to the release of the last guidelines, a large body of evidenc”
Recommendations for chamber quantification. (2006, methodology): “In clinical practice, LV chamber dimensions are commonly used to derive measures of LV systolic function, whereas in epidemiologic studies and treatment trials, the single largest application of echocardiography has been the estimation of LV mass in populations and its change with antihypertensive t”
2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) (2007, background): “Supportive evidence also comes from finding that a BPinduced regression of OD, such as LVH and urinary protein excretion, may be accompanied by a reduction of fatal and nonfatal outcomes [261,262], although this evidence is obviously indirect, being derived from post-hoc correlative analyses of rand”